Literature DB >> 16213663

Metabolic changes in elderly patients with major depression: evidence for increased accumulation of visceral fat at follow-up.

Bettina Weber-Hamann1, Marc Werner, Frank Hentschel, Nils Bindeballe, Florian Lederbogen, Michael Deuschle, Isabella Heuser.   

Abstract

The accumulation of visceral fat is promoted by a specific endocrine syndrome, which is similarly found in major depression. The aim of this study was to investigate whether visceral fat depots increase in depressed patients during a follow-up period explaining the increased risk for cardiovascular disorders. Intraabdominal fat was measured in 29 depressed patients and 17 controls by computer tomography at the level of lumbar vertebra 4. In patients fat measurements were done initially during a major depressive episode and again after a follow-up period of 14 months; in controls the mean time interval between measurements was 28 months. In both groups, saliva was taken at 800 h over a period of seven days prior to each CT for the estimation of free cortisol. In patients only, an oral glucose tolerance test was also carried out. Compared to controls hyper- and normocortisolemic depressed patients showed a larger accumulation of visceral fat mass over time (hypercort.:132.0 +/- 45 vs. 144.7 +/- 47 cm(2), p = 0.07; normocort.: 115.5 +/- 53 vs. 135.0 +/- 51 cm(2), p = 0.002; controls: 130.1 +/- 66 vs. 137.3 +/- 76 cm(2), p = 0.4), despite similar weight gain (hypercort.: 2.1 +/- 5 kg, normocort.: 1.7 +/- 5 kg and controls: 2.3 +/- 4 kg). Further, normocortisolemic patients showed a trend for an higher percentile increase in visceral fat accumulation than controls (23.9 +/- 27 vs. 5.8 +/- 28%, p = 0.07). At follow-up, free cortisol concentrations were still above normal in patients who had been hypercortisolemic at first assessment (35.0 +/- 8 vs. 28.8 +/- 18 nmol/l, p = 0.1). Fasting and 2 h glucose concentrations were higher in hypercortisolemic compared to normocortisolemic patients at the index examination (6.2 +/- 1.1 vs. 5.0 +/- 0.05 mmol/l, p = 0.02; 11.5 +/- 2.7 vs. 7.8 +/- 1.9 mmol/l, p = 0.01). The larger proportion of visceral fat accumulation in patients may constitute a link for explaining the increased cardiovascular mortality in patients suffering from major depression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16213663     DOI: 10.1016/j.psyneuen.2005.08.014

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  21 in total

Review 1.  The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications.

Authors:  Roger S McIntyre; Ka Young Park; Candy W Y Law; Farah Sultan; Amanda Adams; Maria Teresa Lourenco; Aaron K S Lo; Joanna K Soczynska; Hanna Woldeyohannes; Mohammad Alsuwaidan; Jinju Yoon; Sidney H Kennedy
Journal:  CNS Drugs       Date:  2010-09       Impact factor: 5.749

Review 2.  The hypothalamic-pituitary-adrenal axis and serotonin abnormalities: a selective overview for the implications of suicide prevention.

Authors:  Maurizio Pompili; Gianluca Serafini; Marco Innamorati; Anne Maria Möller-Leimkühler; Giancarlo Giupponi; Paolo Girardi; Roberto Tatarelli; David Lester
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-02-20       Impact factor: 5.270

3.  Hypercortisolemic depression is associated with the metabolic syndrome in late-life.

Authors:  Nicole Vogelzangs; Kristen Suthers; Luigi Ferrucci; Eleanor M Simonsick; Alessandro Ble; Matthew Schrager; Stefania Bandinelli; Fulvio Lauretani; Sandra V Giannelli; Brenda W Penninx
Journal:  Psychoneuroendocrinology       Date:  2007-01-16       Impact factor: 4.905

4.  Depressive symptoms and change in abdominal obesity in older persons.

Authors:  Nicole Vogelzangs; Stephen B Kritchevsky; Aartjan T F Beekman; Anne B Newman; Suzanne Satterfield; Eleanor M Simonsick; Kristine Yaffe; Tamara B Harris; Brenda W J H Penninx
Journal:  Arch Gen Psychiatry       Date:  2008-12

Review 5.  Adrenal steroids and the metabolic syndrome.

Authors:  Stephen P Thomson; Craig S Stump; L Romayne Kurukulasuriya; James R Sowers
Journal:  Curr Hypertens Rep       Date:  2007-12       Impact factor: 5.369

6.  Major depression, borderline personality disorder, and visceral fat content in women.

Authors:  Wiebke Greggersen; Sebastian Rudolf; Eva Fassbinder; Leif Dibbelt; Beate M Stoeckelhuber; Fritz Hohagen; Kerstin M Oltmanns; Kai G Kahl; Ulrich Schweiger
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-02-26       Impact factor: 5.270

Review 7.  [Depression and diabetes mellitus type 2].

Authors:  M Deuschle; U Schweiger
Journal:  Nervenarzt       Date:  2012-11       Impact factor: 1.214

8.  Depressive symptoms and increased visceral fat in middle-aged women.

Authors:  Susan A Everson-Rose; Tené T Lewis; Kelly Karavolos; Sheila A Dugan; Deidre Wesley; Lynda H Powell
Journal:  Psychosom Med       Date:  2009-04-27       Impact factor: 4.312

9.  Difference by sex but not by race/ethnicity in the visceral adipose tissue-depressive symptoms association: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Rosemay A Remigio-Baker; Matthew A Allison; Pamela J Schreiner; Moyses Szklo; Rosa M Crum; Jeannie-Marie Leoutsakos; Manuel Franco; Mercedes R Carnethon; Jennifer A Nettleton; Mahasin S Mujahid; Ana V Diez Roux; Nicole Jensky; Sherita H Golden
Journal:  Psychoneuroendocrinology       Date:  2014-05-13       Impact factor: 4.905

10.  Metabolic syndrome is associated with self-perceived depression.

Authors:  Juhani Miettola; Leo K Niskanen; Heimo Viinamäki; Esko Kumpusalo
Journal:  Scand J Prim Health Care       Date:  2008       Impact factor: 2.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.